Literature DB >> 19582849

Preparation of a completely autologous trileaflet valve-shaped construct by in-body tissue architecture technology.

Yasuhide Nakayama1, Masashi Yamanami, Yuki Yahata, Tsutomu Tajikawa, Kenkichi Ohba, Taiji Watanabe, Keiichi Kanda, Hitoshi Yaku.   

Abstract

The aim of this study was to prepare completely autologous heart-valve-shaped constructs without using any artificial scaffold materials by in-body tissue architecture technology, which is a practical concept of regenerative medicine based on the biological defense mechanism against foreign bodies. Silicone rods were used as molds to achieve the tubular shape of the arteries, which were implanted in the subcutaneous spaces of rabbits. After 2 weeks of primary in-body tissue incubation, the silicone rods were completely encapsulated within a thin membranous connective tissue mainly consisting of collagen and having a thickness of approximately 100 microm. To achieve the trileaflet shape of the valve, the cylindrical tissues obtained were rolled up with polyurethane belts cut in the shape of three semi-ovals. The assembled tissues were reimplanted for 2 weeks for secondary incubation. The resulting tissues were over-encapsulated with the newly developed membranous connective tissue having a thickness of approximately 200-400 microm. The newly formed membranes were completely fused to the previously developed inner membrane. After the removal of the two artificial materials, tubular constructs with trileaflet-shaped internal surface were obtained. By controlling the formation of the encapsulating tissue in the two-step in-body tissue incubation process, we were able to develop completely autologous trileaflet valve-shaped constructs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19582849     DOI: 10.1002/jbm.b.31460

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  5 in total

1.  Need for new materials, biofunctionalization and non-surgical heart valve technology.

Authors:  Jan Sochman
Journal:  World J Cardiol       Date:  2010-03-26

2.  In-body optical stimulation formed connective tissue vascular grafts, "biotubes," with many capillaries and elastic fibers.

Authors:  Tomonori Oie; Masashi Yamanami; Hatsue Ishibashi-Ueda; Keiichi Kanda; Hitoshi Yaku; Yasuhide Nakayama
Journal:  J Artif Organs       Date:  2010-09-30       Impact factor: 1.731

3.  Development of an in vivo tissue-engineered valved conduit (type S biovalve) using a slitted mold.

Authors:  Marina Funayama; Maya Furukoshi; Takeshi Moriwaki; Yasuhide Nakayama
Journal:  J Artif Organs       Date:  2015-08-02       Impact factor: 1.731

4.  Preparation of in-vivo tissue-engineered valved conduit with the sinus of Valsalva (type IV biovalve).

Authors:  Masashi Yamanami; Yuki Yahata; Tsutomu Tajikawa; Kenkichi Ohba; Taiji Watanabe; Keiichi Kanda; Hitoshi Yaku; Yasuhide Nakayama
Journal:  J Artif Organs       Date:  2010-03-06       Impact factor: 1.731

5.  In vivo evaluation of an in-body, tissue-engineered, completely autologous valved conduit (biovalve type VI) as an aortic valve in a goat model.

Authors:  Yoshiaki Takewa; Masashi Yamanami; Yuichiro Kishimoto; Mamoru Arakawa; Keiichi Kanda; Yuichi Matsui; Tomonori Oie; Hatsue Ishibashi-Ueda; Tsutomu Tajikawa; Kenkichi Ohba; Hitoshi Yaku; Yoshiyuki Taenaka; Eisuke Tatsumi; Yasuhide Nakayama
Journal:  J Artif Organs       Date:  2012-12-20       Impact factor: 1.731

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.